AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
1. KSF is investigating Akoya's sale to Quanterix Corporation. 2. Shareholders will receive 0.318 shares of Quanterix per Akoya share. 3. Investigation seeks to determine if deal undervalues Akoya. 4. Legal rights regarding the sale can be discussed with KSF. 5. Concerns raised about adequacy of proposed transaction consideration.